Vasculitis and Giant Cell Arteritis

Top Story

Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective

Treatment of Giant Cell Arteritis With Tocilizumab: A Historical Perspective
Healio Rheumatology, November 2017
Gary S. Hoffman, MD, MS, MACR

I am thrilled to have Gary S. Hoffman, MD, MS, MACR, write this month’s Guest Editorial for Healio Rheumatology. No one, in my judgment, is better qualified to help us consider how the recent advances in giant cell arteritis will ultimately effect the way we treat the disease and, of course, ultimately how our patients can potentially benefit from these changes. New therapies must be critically appraised based on a skillful weighing of benefits and risk. We are fortunate to have one of the sages of vasculitis guide us through this process.

— Leonard H. Calabrese, DO

In the Journals

Group formulates treatment plans for NSAID-resistant chronic nonbacterial osteomyelitis

November 15, 2017
Members of the Childhood Arthritis and Rheumatology Research Alliance have developed three consensus treatment plans for patients with chronic nonbacterial…
Meeting News

Renal transplantation linked with reduced mortality in end-stage disease due to GPA

November 9, 2017
SAN DIEGO — Renal transplantation reduced the mortality risk compared with remaining on a waitlist among patients with end-stage renal disease due to…

New studies, technology and criteria improve understanding of vasculitis

October 31, 2017
As a group of rare diseases for which current scientific knowledge is incomplete, vasculitis represents a challenge in both diagnosis and treatment. Although the overall…
More Headlines »

Best of AWIR Immunology Bootcamp

This activity is supported by educational grants from AbbVie, Inc.; Lilly USA, LLC; and Sanofi Genzyme and Regeneron Pharmaceuticals.

Immune-mediated inflammatory disease (IMID) is a group of clinically heterogeneous disorders that share common…
More »
Meeting News

VIDEO: "Modest associations" found between baseline factors, steroid use

December 22, 2016
More »
Resource Centers
American College of Rheumatology Annual Meeting

American College of Rheumatology Annual Meeting


Ace the Case: A 50-Year-Old White Female with a 9-Year History of Rheumatoid Arthritis

There is no commercial support for this activity.

This “Ace the Case” study will explore the diagnosis and management of a 50-year-old white female with a 9-year history…
More »